22 Aug 2017 - 1:44pm

Call us: +44 (0) 207 754 0050

Press Releases in Bioscience Sector

Zaluvida announces Scientific Advisory Board for Mootral New Milestone in Fighting Greenhouse Gas Emissions from Cows

[PRESSWIRE] ROLLE, SWITZERLAND - 03 August, 2017 -- Zaluvida Corporate AG, a Swiss-based pioneering life science company, announced today the formation of the Scientific Advisory Board (SAB) for its Mootral technology that tackles greenhouse gas (GHG) emissions in agriculture.

Zaluvida appoints Daniel de Carvalho as Global Director of Corporate Communications

[PRESSWIRE] ROLLE, SWITZERLAND - 02 August, 2017 -- Zaluvida Corporate AG, a Swiss-based pioneering life science company,  announced today that Daniel de Carvalho joined its leadership team as Global Director of Communications, effective immediately. Zaluvida’s flagship business units, active in the fields of antimicrobial resistance, obesity and reduction of greenhouse gas emissions, are growing steadily. This success established the need for the newly created position to drive the group’s external and internal communications and match the company’s ambitious commercial strategy.

Outcome Capital Expands to Europe With New UK Operations

[PRESSWIRE] BOSTON & LONDON - 28 September, 2016 -- Outcome Capital, LLC (www.outcomecapital.com), an investment banking firm that serves middle market growth companies in life sciences and technology markets, today announced the firm has expanded its operations into Europe with a UK office in London. The company has appointed Shawn Manning, D. Phil., as Managing Director of the new office.

Bioibérica beginnt Studie mit Patienten zur Untersuchung der Wirksamkeit eines neuen Wirkstoffs zur Behandlung der Alzheimerkrankheit

[PRESSWIRE] BARCELONA, Spanien - 09 May, 2016 -- Das Biotechnologieunternehmen Bioibérica und die Fundació ACE Institut Català de Neurociències Aplicades beginnen eine randomisierte, doppelblinde Studie zur Untersuchung der Wirksamkeit und Sicherheit eines neuen ernährungsphysiologischen Wirkstoffs , der den Gedächtnisverlust bei Patienten mit milder Alzheimerkrankheit verlangsamen könnte.


Subscribe to Press Releases in Bioscience Sector